These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22177810)

  • 1. Neglected population of patients receiving intravenous bisphosphonates.
    Annibali S; Bignozzi I; Ottolenghi L; Polimeni A
    J Oral Maxillofac Surg; 2012 Sep; 70(9):2097-8. PubMed ID: 22177810
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness and education of patients receiving bisphosphonates.
    Bauer JS; Beck N; Kiefer J; Stockmann P; Wichmann M; Eitner S
    J Craniomaxillofac Surg; 2012 Apr; 40(3):277-82. PubMed ID: 21612939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cooperation of doctors and dentists in the management of patients taking bisphosphonates].
    Hurni V
    Rev Med Suisse; 2011 Jan; 7(279):247-8. PubMed ID: 21387734
    [No Abstract]   [Full Text] [Related]  

  • 5. Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol.
    Scoletta M; Arata V; Arduino PG; Lerda E; Chiecchio A; Gallesio G; Scully C; Mozzati M
    J Oral Maxillofac Surg; 2013 Jun; 71(6):994-9. PubMed ID: 23434159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dental implications of osteogenesis imperfecta: treatment with IV bisphosphonate: report of a case.
    Milano M; Wright T; Loechner KJ
    Pediatr Dent; 2011; 33(4):349-52. PubMed ID: 21903004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
    Wynn RL
    Gen Dent; 2011; 59(5):330-2. PubMed ID: 22313815
    [No Abstract]   [Full Text] [Related]  

  • 9. What you need to know about bisphosphonates: an overview and general recommendations for orthodontic treatment.
    Abela S; Chotai M; Bister D
    J Orthod; 2012 Sep; 39(3):186-92. PubMed ID: 22984103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Collaboration between doctor and dentist: the example of bisphosphonates].
    Hurni V
    Rev Med Suisse; 2011 Jan; 7(279):198-9. PubMed ID: 21387711
    [No Abstract]   [Full Text] [Related]  

  • 11. [Implants and biphosphonates: 2012 guidelines for practitioners].
    Ruhin B
    Rev Stomatol Chir Maxillofac Chir Orale; 2013 Feb; 114(1):e1-3. PubMed ID: 23711217
    [No Abstract]   [Full Text] [Related]  

  • 12. Implants and biphosphonates: 2012 guidelines for practitioners.
    Ruhin B
    Rev Stomatol Chir Maxillofac Chir Orale; 2013 Feb; 114(1):1-3. PubMed ID: 23711209
    [No Abstract]   [Full Text] [Related]  

  • 13. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?
    Altundag K; Bulut N; Tezcan E; Ozen M; Purnak T
    J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785
    [No Abstract]   [Full Text] [Related]  

  • 14. Taking the lead: sharing best practice in intravenous bisphosphonate use in urological cancers.
    Jensen BT; Dielenseger P; Drudge-Coates L; Flynn K; Hieronymi S; Erik van Muilekom HA; Pieters R; Voss LB
    Eur J Oncol Nurs; 2012 Feb; 16(1):42-53. PubMed ID: 21429796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing medication-related osteonecrosis of the jaw.
    Zebic L; Patel V
    BMJ; 2019 May; 365():l1733. PubMed ID: 31068319
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
    Lewis DM
    J Okla Dent Assoc; 2011; 102(5):36-9. PubMed ID: 21874699
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of bisphosphonate-induced osteonecrosis of the jaw.
    Schilling J
    Northwest Dent; 2008; 87(3):34-5, 37-8, 40. PubMed ID: 18663869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
    J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.